is based on the following papers:

  • Correll CU
    From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics. European Psychiatry 2010; 25: S12–S21.
    DOI 10.1016/S0924-9338(10)71701-6

  • Kusumi I, Boku S, Takahashi Y
    Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis. Psychiatry and clinical neurosciences. 2015; 69(5):243-58.
    DOI 10.1111/pcn.12242

  • Frankel JS, Schwartz TL
    Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole. Therapeutic advances in psychopharmacology. 2017 Jan;7(1):29-41.
    DOI 10.1177/2045125316672136